Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Ledenoverzicht

Traveler01

  • Lid sinds 19 nov 2015

    Laatste bezoek 21 jul 2024

Forumberichten

Frm. Topic / Post Postinfo
BIO

Ofatumumab Demonstrates Superiority Versus Teriflunomide in Two Head-to-Head Phase III Multiple Sclerosis StudiesCompany AnnouncementIn ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoi...

BIO

Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody-CD38Company AnnouncementGenmab signs agreement with Janssen Biotech, Inc. to collaborate exclusively on next...

BIO

July 12, 2018 5:57 AM UTCGenmab Enters Strategic Partnership with Immatics to Discover and Develop Next Generation Bispecific Cancer ImmunotherapiesCompany AnnouncementGenmab gains exclusive a...

BIO

November 8, 2017; Copenhagen, Denmark;Interim Report for the First Nine Months Ended September 30, 2017HighlightsUSD 871 million in net sales of DARZALEX (daratumumab); resulting in ...

BIO

Company AnnouncementNet sales of DARZALEX in the second quarter of 2017 totaled USD 299 millionGenmab will receive royalties on worldwide net sales from Janssen Biotech, Inc.Copenhagen, Denmar...

BIO

May 10, 2017; Copenhagen, Denmark; Interim Report for the First Quarter of 2017HighlightsUSD 255 million in net sales of DARZALEX (daratumumab); resulting in royalty income of DKK 211 ...

BIO

Company AnnouncementCopenhagen, Denmark; February 22, 2017 — Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2016. Below is a summary of business progress and financial ...

BIO

Een nieuwe aanpassing van de op 22 februari te publiceren cijfers.Company AnnouncementCopenhagen, Denmark; February 6, 2017 — Genmab A/S (Nasdaq Copenhagen: GEN) announced today that it has ...

BIO

ir.genmab.com/releasedetail.cfm?Relea...derde kwartaal Genmab...

BIO

ir.genmab.com/releasedetail.cfm?Relea...Daratumumab Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration in Combination with Standard of Care Regimens fo...

BIO

The trial is the latest in a string of successful studies of Darzalex, which JJ is co-developing with Danish biotech group Genmab, prompting Jefferies analyst Peter Welford to estimate that the d...

BIO

2,5 miljoen stuks in de eindveiling. Iemand een idee?...